What scans are used to confirm macular degeneration? 

The diagnosis and confirmation of age-related macular degeneration (AMD) have been transformed by advanced imaging technology that allows clinicians to see beneath the surface of the retina. In the United Kingdom, confirming the presence, type, and severity of AMD is a multi-step process involving specialized scans that map the layers of the macula in high resolution. These tools are essential not only for identifying the characteristic drusen of dry AMD but also for detecting the fluid and abnormal blood vessel growth that define the more urgent wet form of the condition. By using these non-invasive imaging techniques, UK ophthalmologists can provide an accurate diagnosis and tailor a treatment plan that offers the best possible protection for a patient’s central vision. 

What We’ll Discuss in This Article 

• The role of Optical Coherence Tomography (OCT) as the gold standard for diagnosis. 

• How digital fundus photography creates a visual baseline of the retina. 

• The use of fundus autofluorescence (FAF) to track geographic atrophy. 

• Fluorescein angiography and its role in identifying leaking blood vessels. 

• Indocyanine green angiography (ICG) for complex or deep vascular issues. 

• How these scans are integrated into the UK clinical referral pathway. 

Optical Coherence Tomography (OCT) 

Optical Coherence Tomography, commonly known as an OCT scan, is the primary tool used to confirm a diagnosis of macular degeneration. It is a non-invasive imaging test that uses light waves to take cross sectional pictures of the retina. This allows a specialist to see each of the retina’s individual layers in 3D, much like an ultrasound but with significantly higher resolution. 

An OCT scan is vital because it can “see” fluid, swelling, or structural changes that are not visible during a standard physical examination. In dry AMD, the scan shows the thinning of the retinal layers and the elevation caused by drusen. In wet AMD, the scan identifies precisely where fluid is accumulating (oedema) and whether it is under or within the retina. In the UK, most hospital eye departments use OCT to monitor the effectiveness of treatments such as anti VEGF injections. 

Digital fundus photography 

Digital fundus photography involves using a specialized camera to take a high resolution, 2D photograph of the back of the eye. This provides a clear “map” of the retina, the macula, and the optic nerve. These photographs are used to document the physical appearance of the eye at a specific point in time, allowing clinicians to spot drusen, pigment changes, or areas of haemorrhage (bleeding). 

The primary value of fundus photography is for longitudinal comparison. By comparing current photographs with those taken during previous visits, a UK optometrist or ophthalmologist can detect subtle changes in the size and number of drusen, which indicates the progression of dry AMD. This provides an objective record of the disease’s stability or decline. More information on diagnostic imaging standards is provided by the Macular Society. 

Fundus Autofluorescence (FAF) 

Fundus Autofluorescence (FAF) is a specialized type of imaging that highlights the health of the retinal pigment epithelium (RPE), the layer of cells that nourishes the macula. This scan detects a natural fluorescent signal from a waste product called lipofuscin. When RPE cells are stressed or dying, the level of fluorescence changes, appearing as bright or dark patches on the scan. 

FAF is particularly useful for confirming and tracking geographic atrophy, which is the advanced stage of dry AMD. It allows doctors to measure the exact size of the “atrophic” (dead) patches of tissue and predict how quickly the area of vision loss might expand. In the UK, FAF is an essential tool for monitoring patients who are not suitable for injections but require close observation of their retinal health. 

Fluorescein Angiography (FA) 

Fluorescein angiography is a diagnostic procedure used to confirm the presence of wet AMD by mapping the blood vessels in the retina. A special yellow dye (fluorescein) is injected into a vein in the arm. As the dye travels through the blood vessels in the eye, a camera takes a series of photographs to see if any of the dye is leaking out. 

If the photographs show the dye “pooling” or leaking into the macula, it confirms that abnormal, fragile blood vessels have formed the hallmark of wet AMD. This scan helps the specialist determine exactly where the leakage is occurring and how aggressive the condition is. Under NICE guidance, fluorescein angiography is often used at the first hospital appointment to confirm the need for injection therapy. 

Indocyanine Green Angiography (ICGA) 

Indocyanine green angiography (ICGA) is similar to fluorescein angiography but uses a different type of dye that is better at showing the deeper blood vessels located behind the retina (the choroid). This scan is less commonly used than FA but is invaluable in specific or complex cases where the standard scans do not provide a clear enough picture. 

ICGA is particularly useful for identifying a variant of AMD called polypoidal choroidal vasculopathy (PCV), which can mimic the symptoms of standard wet AMD but may require a different treatment approach. By using ICGA, UK specialists can ensure they have the most complete understanding of the vascular issues affecting the patient’s macula. 

Summary of Diagnostic Scans for AMD 

Scan Type	Primary Function	Best For
OCT Scan	3D cross-section of layers	Confirming fluid and retinal thinning
Fundus Photo	2D surface image	Baseline monitoring and drusen tracking
FAF Scan	Maps RPE cell health	Monitoring advanced dry AMD (Geographic Atrophy)
Fluorescein Angio	Maps vessel leakage	Confirming and locating wet AMD activity
ICG Angio	Maps deeper vessels	Complex cases or deep vascular issues

The integration of scans into UK care pathways 

In the United Kingdom, the diagnostic journey usually starts with an OCT scan at a high street optometrist. If the scan shows fluid or significant changes, the patient is referred to a hospital eye clinic. At the hospital, the ophthalmologist will likely repeat the OCT and may perform fluorescein angiography to confirm the diagnosis before starting treatment. 

This multi scan approach ensures that the diagnosis is accurate and that the specific type of AMD is identified. Once treatment begins, the OCT scan remains the primary tool for monitoring. Patients typically have an OCT scan at every follow up appointment to determine if their “wet” activity has dried up or if they require another injection. This evidence-based approach is central to the standards of care set by The Royal College of Ophthalmologists. 

Conclusion 

Confirming a diagnosis of macular degeneration relies on a sophisticated range of scans, with OCT serving as the most critical tool for identifying both dry and wet forms. While photographs and autofluorescence help track the slow progression of dry AMD, angiography remains the definitive method for confirming the active leakage of wet AMD. In the UK, these imaging technologies ensure that patients receive a precise diagnosis and timely access to sight saving treatments. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot 

This article provides an evidence-based overview of the diagnostic imaging used to confirm macular degeneration in the UK. It was written by the Medical Content Team and reviewed by Dr. Rebecca Fernandez, a UK trained physician with experience in internal medicine and emergency care. The content is strictly aligned with the clinical diagnostic protocols established by the NHS and the National Institute for Health and Care Excellence (NICE) for retinal health.